Previous Question
185. A critical situational clinical trial reports that a new drug for a chronic condition is statistically significant, but the observed effect size is very small (e.g., 0.1% improvement). What is the urgency for a biostatistician to contextualize this finding?
Next Question
187. A clinical researcher wants to compare the proportion of patients who discontinue treatment (yes/no) in a new drug group versus a standard care group. Which technical statistical test is most appropriate?
